AGHEMO, Alessio Michele Goffredo
AGHEMO, Alessio Michele Goffredo
Dipartimento Scienze Biomediche
12 weeks ombitasvir/paritaprevir-ritonavir plus ribavirin achieve high SVR rates in HCV-4 patients with advanced fibrosis
2018-01-01 Degasperi, E; Aghemo, A; Paolucci, S; D'Ambrosio, R; Borghi, M; Perbellini, R; Novazzi, F; De Nicola, S; Lunghi, G; Baldanti, F; Lampertico, P
A 13-day, interferon-free regimen for chronic hepatitis C genotype 1 patients: between fear and hope.
2011-01-01 Aghemo, A; Colombo, M.
A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
2012-01-01 D'Ambrosio, R; Aghemo, A; Rumi, Mg; Ronchi, G; Donato, Mf; Paradis, V; Colombo, M; Bedossa, P
A rapid point-of-care test for the diagnosis of HCV infection: tipping the balance to screening extension beyond high risk populations?
2011-01-01 Aghemo, A; Colombo, M.
A Review of the Treatment of Chronic Hepatitis C Virus Infection in Cirrhosis
2010-01-01 Vezali, E; Aghemo, A; Colombo, M
A risk score based on baseline risk factors for predicting mortality in COVID-19 patients
2021-01-01 Chen, Ze; Chen, Jing; Zhou, Jianghua; Lei, Fang; Zhou, Feng; Qin, Juan-Juan; Zhang, Xiao-Jing; Zhu, Lihua; Liu, Ye-Mao; Wang, Haitao; Chen, Ming-Ming; Zhao, Yan-Ci; Xie, Jing; Shen, Lijun; Song, Xiaohui; Zhang, Xingyuan; Yang, Chengzhang; Liu, Weifang; Zhang, Xiao; Guo, Deliang; Yan, Youqin; Liu, Mingyu; Mao, Weiming; Liu, Liming; Ye, Ping; Xiao, Bing; Luo, Pengcheng; Zhang, Zixiong; Lu, Zhigang; Wang, Junhai; Lu, Haofeng; Xia, Xigang; Wang, Daihong; Liao, Xiaofeng; Peng, Gang; Liang, Liang; Yang, Jun; Chen, Guohua; Azzolini, Elena; Aghemo, Alessio; Ciccarelli, Michele; Condorelli, Gianluigi; Stefanini, Giulio G; Wei, Xiang; Zhang, Bing-Hong; Huang, Xiaodong; Xia, Jiahong; Yuan, Yufeng; She, Zhi-Gang; Guo, Jiao; Wang, Yibin; Zhang, Peng; Li, Hongliang
Absolute targets for HCV elimination and national health policy paradigms: Foreseeing future requirements
2021-01-01 Kondili, Loreta A.; Craxì, Antonio; Aghemo, Alessio
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
2019-01-01 Cooke, Gs; Andrieux-Meyer, I; Applegate, Tl; Atun, R; Burry, Jr; Cheinquer, H; Dusheiko, G; Feld, Jj; Gore, C; Griswold, Mg; Hamid, S; Hellard, Me; Hou, Jl; Howell, J; Jia, Jd; Kravchenko, N; Lazarus, Jv; Lemoine, M; Lesi, Oa; Maistat, L; Mcmahon, Bj; Razavi, H; Roberts, Tr; Simmons, B; Sonderup, Mw; Spearman, Cw; Taylor, Be; Thomas, Dl; Waked, I; Ward, Jw; Wiktor, Sz; Abdo, A; Aggarwal, R; Aghemo, A; Al-Judaibi, B; Al Mahtab, M; Altaf, A; Ameen, Z; Asselah, T; Baatarkkhuu, O; Barber, E; Barnes, E; Boulet, P; Burrows, L; Butsashvili, M; Chan, E; Chow, C; Cowie, B; Cunningham, C; de Araujo, A; Diap, G; Dore, G; Doyle, J; Elsayed, M; Fajardo, E; Gane, E; Getehun, A; Goldberg, D; Got, T; Hickman, M; Hill, A; Howell, J; Hutchinson, S; Jones, C; Kamili, S; Khan, A; Lee, A; Lee, Ty; Malani, J; Morris, Tm; Nayagam, S; Njouom, R; Ocama, P; Pedrana, A; Peeling, R; Reddy, A; Roberts, T; Sacks, J; Sarin, S; Shimakawa, Y; Silva, M; Skala, P; Taylor-Robinson, S; Thompson, A; Thursz, M; Tonganibeia, A; Wallace, J; Ward, J; Wolff, F; Vickerman, P; Yau, J
Acute allograft rejection following interferon therapy for hepatitis C in recipients who have returned to dialysis after kidney transplant failure: Case study
2014-01-01 Fabrizi, F; D'Ambrosio, R; Pallotti, F; Berardinelli, L; Messa, P; Martin, P; Aghemo, A
Acute tubular necrosis following interferon-based therapy for hepatitis C : case study with literature review
2014-01-01 Fabrizi, F.; Aghemo, A.; Fogazzi, G. B.; Moroni, G.; Passerini, P.; D'Ambrosio, R.; Messa, P.
Adherence to pan-genotypic glecaprevir/pibrentasvir and efficacy in HCV-infected patients: A pooled analysis of clinical trials
2020-01-01 Brown, A; Welzel, Tm; Conway, B; Negro, F; Brau, N; Grebely, J; Puoti, M; Aghemo, A; Kleine, H; Pugatch, D; Mensa, Fj; Chen, Yzj; Lei, Y; Lawitz, E; Asselah, T
Age Might Confound the Impact of the Transmembrane 6 Superfamily Member 2 E167K Polymorphism on Hepatic Fibrosis in Hepatitis C Virus-Infected Patients REPLY
2016-01-01 Romeo, S.; Aghemo, A.; Berg, T.; Stickel, F.; Valenti, L.
All That Glitters is Not Gold in Vedolizumab Therapy for Patients With Inflammatory Bowel Diseases and Primary Sclerosing Cholangitis
2020-01-01 Roda, G; Lleo de nalda, A; Danese, S; Aghemo, A
Allelic inhibition of displacement activity: A simplified one tube allele-specific PCR for evaluation of ITPA polymorphisms
2013-01-01 Galmozzi, E; Facchetti, F; Degasperi, E; Aghemo, A; Lampertico, P
Alpha-fetoprotein screening in patients with hepatitis C-induced cirrhosis who achieved a sustained virologic response in the direct-acting antiviral agents era
2018-01-01 Spadaccini, M; Lleo, A; Ceriani, R; Covini, G; Rimassa, L; Torzilli, G; Di Tommaso, L; Aghemo, A
An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naive patients with genotype 1 chronic hepatitis C
2014-01-01 Andriulli, A; Nardi, A; Di Marco, V; Ippolito, Am; Gavrila, C; Aghemo, A; Di Paolo, D; Squadrito, G; Grassi, E; Calvaruso, V; Valvano, Mr; Brancaccio, G; Craxi, A; Angelico, M
An individualized algorithm to predict mortality in COVID-19 pneumonia: a machine learning based study
2022-01-01 Laino, Maria Elena; Generali, Elena; Tommasini, Tobia; Angelotti, Giovanni; Aghemo, Alessio; Desai, Antonio; Morandini, Pierandrea; Stefanini, Giulio G; Lleo, Ana; Voza, Antonio; Savevski, Victor
Anemia during peginterferon-ribavirin therapy results from both increased suppression of erythroid differentiation and haemolysis
2008-01-01 Aghemo, A.; Ronzoni, L.; Rumi, M.; Monico, S.; Colancecco, A.; Grillo, P.; Viganò, M.; Cappellini, M. D.; Colombo, M.
Anti-TNF drugs in patients with hepatitis B or C virus infection: safety and clinical management
2012-01-01 Vigano, M; Degasperi, E; Aghemo, A; Lampertico, P; Colombo, M
Assessing long-term treatment efficacy in chronic hepatitis B and C : Between evidence and common sense
2012-01-01 Aghemo, A.; Lampertico, P.; Colombo, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 12 weeks ombitasvir/paritaprevir-ritonavir plus ribavirin achieve high SVR rates in HCV-4 patients with advanced fibrosis | 1-gen-2018 | Degasperi, E; Aghemo, A; Paolucci, S; D'Ambrosio, R; Borghi, M; Perbellini, R; Novazzi, F; De Nicola, S; Lunghi, G; Baldanti, F; Lampertico, P | |
| A 13-day, interferon-free regimen for chronic hepatitis C genotype 1 patients: between fear and hope. | 1-gen-2011 | Aghemo, A; Colombo, M. | |
| A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis | 1-gen-2012 | D'Ambrosio, R; Aghemo, A; Rumi, Mg; Ronchi, G; Donato, Mf; Paradis, V; Colombo, M; Bedossa, P | |
| A rapid point-of-care test for the diagnosis of HCV infection: tipping the balance to screening extension beyond high risk populations? | 1-gen-2011 | Aghemo, A; Colombo, M. | |
| A Review of the Treatment of Chronic Hepatitis C Virus Infection in Cirrhosis | 1-gen-2010 | Vezali, E; Aghemo, A; Colombo, M | |
| A risk score based on baseline risk factors for predicting mortality in COVID-19 patients | 1-gen-2021 | Chen, Ze; Chen, Jing; Zhou, Jianghua; Lei, Fang; Zhou, Feng; Qin, Juan-Juan; Zhang, Xiao-Jing; Zhu, Lihua; Liu, Ye-Mao; Wang, Haitao; Chen, Ming-Ming; Zhao, Yan-Ci; Xie, Jing; Shen, Lijun; Song, Xiaohui; Zhang, Xingyuan; Yang, Chengzhang; Liu, Weifang; Zhang, Xiao; Guo, Deliang; Yan, Youqin; Liu, Mingyu; Mao, Weiming; Liu, Liming; Ye, Ping; Xiao, Bing; Luo, Pengcheng; Zhang, Zixiong; Lu, Zhigang; Wang, Junhai; Lu, Haofeng; Xia, Xigang; Wang, Daihong; Liao, Xiaofeng; Peng, Gang; Liang, Liang; Yang, Jun; Chen, Guohua; Azzolini, Elena; Aghemo, Alessio; Ciccarelli, Michele; Condorelli, Gianluigi; Stefanini, Giulio G; Wei, Xiang; Zhang, Bing-Hong; Huang, Xiaodong; Xia, Jiahong; Yuan, Yufeng; She, Zhi-Gang; Guo, Jiao; Wang, Yibin; Zhang, Peng; Li, Hongliang | |
| Absolute targets for HCV elimination and national health policy paradigms: Foreseeing future requirements | 1-gen-2021 | Kondili, Loreta A.; Craxì, Antonio; Aghemo, Alessio | |
| Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission | 1-gen-2019 | Cooke, Gs; Andrieux-Meyer, I; Applegate, Tl; Atun, R; Burry, Jr; Cheinquer, H; Dusheiko, G; Feld, Jj; Gore, C; Griswold, Mg; Hamid, S; Hellard, Me; Hou, Jl; Howell, J; Jia, Jd; Kravchenko, N; Lazarus, Jv; Lemoine, M; Lesi, Oa; Maistat, L; Mcmahon, Bj; Razavi, H; Roberts, Tr; Simmons, B; Sonderup, Mw; Spearman, Cw; Taylor, Be; Thomas, Dl; Waked, I; Ward, Jw; Wiktor, Sz; Abdo, A; Aggarwal, R; Aghemo, A; Al-Judaibi, B; Al Mahtab, M; Altaf, A; Ameen, Z; Asselah, T; Baatarkkhuu, O; Barber, E; Barnes, E; Boulet, P; Burrows, L; Butsashvili, M; Chan, E; Chow, C; Cowie, B; Cunningham, C; de Araujo, A; Diap, G; Dore, G; Doyle, J; Elsayed, M; Fajardo, E; Gane, E; Getehun, A; Goldberg, D; Got, T; Hickman, M; Hill, A; Howell, J; Hutchinson, S; Jones, C; Kamili, S; Khan, A; Lee, A; Lee, Ty; Malani, J; Morris, Tm; Nayagam, S; Njouom, R; Ocama, P; Pedrana, A; Peeling, R; Reddy, A; Roberts, T; Sacks, J; Sarin, S; Shimakawa, Y; Silva, M; Skala, P; Taylor-Robinson, S; Thompson, A; Thursz, M; Tonganibeia, A; Wallace, J; Ward, J; Wolff, F; Vickerman, P; Yau, J | |
| Acute allograft rejection following interferon therapy for hepatitis C in recipients who have returned to dialysis after kidney transplant failure: Case study | 1-gen-2014 | Fabrizi, F; D'Ambrosio, R; Pallotti, F; Berardinelli, L; Messa, P; Martin, P; Aghemo, A | |
| Acute tubular necrosis following interferon-based therapy for hepatitis C : case study with literature review | 1-gen-2014 | Fabrizi, F.; Aghemo, A.; Fogazzi, G. B.; Moroni, G.; Passerini, P.; D'Ambrosio, R.; Messa, P. | |
| Adherence to pan-genotypic glecaprevir/pibrentasvir and efficacy in HCV-infected patients: A pooled analysis of clinical trials | 1-gen-2020 | Brown, A; Welzel, Tm; Conway, B; Negro, F; Brau, N; Grebely, J; Puoti, M; Aghemo, A; Kleine, H; Pugatch, D; Mensa, Fj; Chen, Yzj; Lei, Y; Lawitz, E; Asselah, T | |
| Age Might Confound the Impact of the Transmembrane 6 Superfamily Member 2 E167K Polymorphism on Hepatic Fibrosis in Hepatitis C Virus-Infected Patients REPLY | 1-gen-2016 | Romeo, S.; Aghemo, A.; Berg, T.; Stickel, F.; Valenti, L. | |
| All That Glitters is Not Gold in Vedolizumab Therapy for Patients With Inflammatory Bowel Diseases and Primary Sclerosing Cholangitis | 1-gen-2020 | Roda, G; Lleo de nalda, A; Danese, S; Aghemo, A | |
| Allelic inhibition of displacement activity: A simplified one tube allele-specific PCR for evaluation of ITPA polymorphisms | 1-gen-2013 | Galmozzi, E; Facchetti, F; Degasperi, E; Aghemo, A; Lampertico, P | |
| Alpha-fetoprotein screening in patients with hepatitis C-induced cirrhosis who achieved a sustained virologic response in the direct-acting antiviral agents era | 1-gen-2018 | Spadaccini, M; Lleo, A; Ceriani, R; Covini, G; Rimassa, L; Torzilli, G; Di Tommaso, L; Aghemo, A | |
| An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naive patients with genotype 1 chronic hepatitis C | 1-gen-2014 | Andriulli, A; Nardi, A; Di Marco, V; Ippolito, Am; Gavrila, C; Aghemo, A; Di Paolo, D; Squadrito, G; Grassi, E; Calvaruso, V; Valvano, Mr; Brancaccio, G; Craxi, A; Angelico, M | |
| An individualized algorithm to predict mortality in COVID-19 pneumonia: a machine learning based study | 1-gen-2022 | Laino, Maria Elena; Generali, Elena; Tommasini, Tobia; Angelotti, Giovanni; Aghemo, Alessio; Desai, Antonio; Morandini, Pierandrea; Stefanini, Giulio G; Lleo, Ana; Voza, Antonio; Savevski, Victor | |
| Anemia during peginterferon-ribavirin therapy results from both increased suppression of erythroid differentiation and haemolysis | 1-gen-2008 | Aghemo, A.; Ronzoni, L.; Rumi, M.; Monico, S.; Colancecco, A.; Grillo, P.; Viganò, M.; Cappellini, M. D.; Colombo, M. | |
| Anti-TNF drugs in patients with hepatitis B or C virus infection: safety and clinical management | 1-gen-2012 | Vigano, M; Degasperi, E; Aghemo, A; Lampertico, P; Colombo, M | |
| Assessing long-term treatment efficacy in chronic hepatitis B and C : Between evidence and common sense | 1-gen-2012 | Aghemo, A.; Lampertico, P.; Colombo, M. |